1-deamino-8-D-arginine vasopressin and cryoprecipitate in variant von Willebrand disease

Academic Article
uri icon

publication date

  • 1985

abstract

  • The effect of infusing DDAVP and cryoprecipitate either singly or in combination was studied in a patient with variant von Willebrand disease. Both DDAVP and cryoprecipitate caused only partial correction in the hemostatic defect when used as a single agent. A combination of DDAVP and cryoprecipitate induced a complete correction of the hemostatic defect as well as factor VIII related properties.